Printer Friendly
The Free Library
21,435,892 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CellQuest, Tampa, FL, March 1 (Florida).

The agency objected to the company's promotion of the products CellQuest Liquid and CellQuest Gel on its website. According to the warning letter, the company was assigning several healing attributes to the products, which would cause them to be unapproved un·ap·proved  
adj.
Not approved or sanctioned: an unapproved vaccine; an unapproved protest march. 
 drugs.

Examples of some of these claims included CellQuest as being able to stop "the growth of certain tested malignant tumor malignant tumor
n.
A tumor that invades surrounding tissues, is usually capable of producing metastases, may recur after attempted removal, and is likely to cause death unless adequately treated.
 lines" and being used for "combating debilitating de·bil·i·tat·ing
adj.
Causing a loss of strength or energy.


Debilitating
Weakening, or reducing the strength of.

Mentioned in: Stress Reduction
 diseases."

Furthermore, the site also claimed testimonials, such as: "His cancer disappeared-without radiation or chemotherapy" and "[CellQuest] prevents cancer cells from dividing." NDA (Non Disclosure Agreement) An agreement signed between two parties that have to disclose confidential information to each other in order to do business. In general, the NDA states why the information is being divulged and stipulates that it cannot be used for any , Web; Doc. 13441 W
COPYRIGHT 2005 Washington Information Source, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:HUMAN DRUGS & DIETARY SUPPLEMENTS
Publication:Warning Letter Bulletin
Date:May 1, 2005
Words:95
Previous Article:Alcon Labs, Forth Worth, TX, April 27, (DDMAC).
Next Article:Chi Machine International, Studio City, CA, Jan. 7 (CFSAN).



Related Articles
FOODS/DIETARY SUPPLEMENTS.
Food/dietary supplements.
Foods/dietary supplements.
Human drugs.
ASCPT panel releases position statement on dietary supplement oversight.
Valensa receives FDA & FSA notifications for Zanthin.
Pet supplements primer: understanding the rules in the pet supplement market.
DSEA launches new ad campaign.

Terms of use | Copyright © 2013 Farlex, Inc. | Feedback | For webmasters | Submit articles